Search

everythinglearnresearchcommunity

for

Search:↓

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

A 6-year-old boy developed excessive hair growth after taking diazoxide for low blood sugar.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

A new method efficiently creates biaryl N-oxides with potential for cancer treatment and drug development.

A new method efficiently modifies alkenes to create useful medicinal compounds.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

A rigid compound with a common structural motif was successfully synthesized.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

A new compound shows promise as a topical treatment for hair loss.

New micelle solutions greatly improve skin delivery of certain antifungal drugs.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

A new method creates valuable compounds for drug discovery by breaking traditional chemical rules.

Better diagnosis and control of thallium poisoning are needed to prevent severe outcomes.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Fluconazole might be a new treatment for a type of diabetes that affects water balance in the body.

These drugs cause hair growth without affecting testosterone or adrenal hormones.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

N13-substituted evodiamine derivatives improved anticancer activity and solubility, showing promise for drug development.

A new compound effectively inhibits human 5α-reductase 1.

Advanced delivery systems can make dithranol more effective and less irritating for treating psoriasis.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Topical sulfonylurea may reduce excessive hair growth caused by certain medications.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.